Our focus at ReNeuron is on our CustomEx exosome technology platform, producing exosomes with unique tissue targeting tropisms to deliver a payload of choice to a preferred cell type. Our mission is to partner and develop novel exosome therapeutics for diseases with significant unmet needs.
View Top Employees from ReNeuron Group PlcWebsite | http://www.reneuron.com |
Ticker | RENE |
Revenue | $3 million |
Employees | 52 (52 on RocketReach) |
Founded | 1997 |
Phone | +44 20 3819 8400 |
Fax | +44 483534864 |
Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Drug Manufacturing & Research, Pharmaceuticals, Science and Engineering, Drug Discovery, Healthcare, Medical, Health Care, Therapeutics |
Web Rank | 3 Million |
Keywords | Reneuron, Reneuron Group, Uk Green Light For Reneuron Stem Cell Therapy Trials, "St. James Mgp", Randolph Corteling Reneuron, Cardiff, Uk (#59) |
Competitors | Athersys, Mesoblast Limited, Promethera Biosciences, Q Therapeutics, Semma Therapeutics |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies |
Looking for a particular ReNeuron Group Plc employee's phone or email?
The ReNeuron Group Plc annual revenue was $3 million in 2024.
Randolph Corteling is the Chief Scientific Officer of ReNeuron Group Plc.
52 people are employed at ReNeuron Group Plc.
The NAICS codes for ReNeuron Group Plc are [54, 5417, 541, 54171, 541714].
The SIC codes for ReNeuron Group Plc are [87, 873].